Invesco Ltd. Decreases Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Invesco Ltd. cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 1.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 6,033,896 shares of the healthcare conglomerate's stock after selling 87,364 shares during the period. UnitedHealth Group comprises approximately 0.6% of Invesco Ltd.'s holdings, making the stock its 14th largest position. Invesco Ltd. owned approximately 0.66% of UnitedHealth Group worth $3,052,307,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of UNH. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter worth $25,000. Hurley Capital LLC bought a new stake in UnitedHealth Group during the fourth quarter valued at about $28,000. Aster Capital Management DIFC Ltd bought a new position in shares of UnitedHealth Group in the fourth quarter worth about $30,000. AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group during the 4th quarter valued at approximately $30,000. Finally, Promus Capital LLC bought a new stake in UnitedHealth Group during the 4th quarter worth approximately $32,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction dated Friday, January 17th. The stock was purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company's stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.33% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on UNH. KeyCorp reissued an "overweight" rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Hsbc Global Res upgraded UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 10th. Truist Financial decreased their target price on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a research note on Monday, January 6th. StockNews.com raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. Finally, Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research report on Tuesday, January 28th. Twenty investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Buy" and an average price target of $629.32.

Remove Ads

UnitedHealth Group Trading Down 2.9 %

Shares of UNH opened at $524.94 on Monday. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company's fifty day simple moving average is $509.24 and its 200-day simple moving average is $541.85. The company has a market cap of $480.17 billion, a P/E ratio of 33.87, a P/E/G ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. During the same quarter in the prior year, the firm posted $5.83 earnings per share. The company's quarterly revenue was up 6.8% on a year-over-year basis. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.60%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio is 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.